Columbus chronic disease startup lands distribution deal with Labcorp


Redi.Health Inc.'s app is now offered to patients through the Patient Access Solutions division of Labcorp, a global diagnostic and drug development company.

Previous FDA approves Krystal Biotech clinical trial
Next Healthcare Heroes: OSU nurse Jessica Curtisi finds new calling after treating Covid patients